Methods and materials for assessing immune system profiles
AssigneeMayo Foundation for Medical Education and Research
InventorsAllan B. Dietz, Michael P. Gustafson
Life of this patent
Estimating the term…
Abstract
This document provides methods and materials involved in assessing immune system profiles. For example, methods and materials for performing flow cytometry to determine the number of CD4+ lymphocytes, CD8+ lymphocytes, regulatory T cells, B cells, NK cells, granulocytes, CD14+HLA-DRlo/neg g monocytes, and/or CD86+ monocytes per unit volume (e.g., cells per μL or mL) of whole blood (e.g., fresh, un-manipulated whole blood) obtained from a mammal (e.g., a human) are provided.
Claims3
A method for treating a human having renal cell carcinoma, wherein said method comprises:
- (a) performing flow cytometry using a blood sample obtained from a human having renal cell carcinoma to identify said human as having, per μL of whole blood, from about 3000 to about 9000 granulocytes, from about 950 to about 2500 lymphocytes, from about 350 to about 750 monocytes, from about 650 to about 1750 T cells, from about 50 to about 400 B cells, from about 100 to about 300 NK cells, from about 500 to about 1175 CD4+ lymphocytes, from about 5 to about 55 regulatory T cells, from about 10 to about 185 CD14+HLA-DRlo/neg monocytes, and from about 325 to about 650 CD86+ monocytes, and
- (b) administering surgery, IL-2, or cryotherapy to said human.
A method for treating a human having renal cell carcinoma, wherein said method comprises administering surgery, IL-2, or cryotherapy to a human identified as having said renal cell carcinoma and as having, per μL of whole blood, from about 3000 to about 9000 granulocytes, from about 950 to about 2500 lymphocytes, from about 350 to about 750 monocytes, from about 650 to about 1750 T cells, from about 50 to about 400 B cells, from about 100 to about 300 NK cells, from about 500 to about 1175 CD4+ lymphocytes, from about 5 to about 55 regulatory T cells, from about 10 to about 185 CD14+HLA-DRlo/neg monocytes, and from about 325 to about 650 CD86+ monocytes.
Dependencies are inferred from the claim text.